The pharmacological treatment of panic disorder is limited.
One of the few animal models of panic is the response to KCN injection in rats.
The KCN model is useful for screening new potential treatments for panic disorder.
Cannabinoid compounds, which may alleviate anxiety, failed to inhibit KCN effects.
Alprazolam, a benzodiazepine, abolished KCN behavioral and cardiovascular effects.